References
  1. International Agency for Research on Cancer. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. http://gco.iarc.fr/. Accessed October 09, 2017.
  2. Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians. 2016;66(1): 7-30. DOI: 10.3322/caac.21332
  3. Adeola HA, Afrogheh AH, Hille JJ. The burden of head and neck cancer in Africa: the status quo and research prospects. SADJ. 2018 September; 73(8): 477-488.
  4. Ayo-Yusuf OA, Lalloo R, Johnson NW. Trends and ethnic disparities in oral and oro-pharyngeal cancers in South Africa, 1992-2001. Journal of the South African Dental Association 2013;68(4):168-73.
  5. Ridge AR, Mehra R, Lango MN, Galloway T. Head and Neck Tumors. Cancer Network Home of Journal Oncology. http://www.cancernetwork.com/cancer-management/head-and-neck-tumors. Published June 2, 2016. Accessed October 1, 2017.
  6. Leoncini E, Vukovic V, Cadoni G, Pastorino R, Arzani D, Bosetti C, et al. Clinical features and prognostic factors in patients with head and neck cancer: Results from a multicentric study. Cancer Epidemiology. 2015;39(3): 367-374. https://doi.org/10.1016/j.canep.2015.02.004.
  7. Alvarenga L, Ruiz MT, Pavarino-Bertelli EC, Ruback MJ, Maniglia JV, Goloni-Bertollo M. Epidemiologic evaluation of head and neck patients in a university hospital of Northwestern São Paulo State. Brazilian Journal of Otorhinolaryngology. 2008; 74(1):68-73. http://dx.doi.org/10.1590/S1516-31802012000500007.
  8. Erinoso OA, Okoturo E, NA Awolola, SS Soyemi, RT Oluwakuyide. Emerging trends in the Epidemiological Pattern of Head and Neck Cancers in Lagos, Nigeria. Annals of Medical & Health Sciences Research. 2016 Sep-Oct; 6(5): 301-7. doi: 10.4103/amhsr.amhsr_30_16.
  9. Fomete B, AgbaraR, Adebayo ET, Osunde OD, Adelola DS. An epidemiological study of 270 cases of carcinoma of the head and neck region in a Nigerian tertiary health care facility. Egyptian Journal of Ear, Nose, Throat and Allied Sciences. 2017; 18(2017): 251-5. https://doi.org/10.1016/j.ejenta.2017.11.003
  10. Stenson KM, Brockstein BE, Connor RF. Epidemiology and risk factors for head and neck cancer. UpToDate. https://www.uptodate.com/contents/epidemiology-and-risk-factors-for-head-and-neck-cancer. Updated 2019. Accessed September 20, 2017.
  11. World Health Organization International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to Humans. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438. https://www.ncbi.nlm.nih.gov/books/NBK316407. Published 2004. Accessed September 20, 2017.
  12. Human Sciences Research Council. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Human Sciences Research Council website. http://www.hsrc.ac.za/en/research-outputs/view/6871. Published 2014. Accessed January 17,2018.
  13. McLemore MS, Haigentz M, Smith RV, Nuovo GJ, Alos L, CardesaA,et al Head and Neck Squamous Cell Carcinomas in HIV-Positive Patients: A Preliminary Investigation of Viral Associations. Head Neck Pathol. 2010 Jun; 4(2): 97–105. doi: 10.1007/s12105-010-0171-9
  14. Al-Dakkak I. Socioeconomic status and head and neck cancer. Evid Based Dent. 2010;11(2):57-8. doi: 10.1038/sj.ebd.6400726.
  15. Johnson S, McDonald JT, Corsten MJ. Socioeconomic factors in head and neck cancer. Otolaryngol Head Neck Surg. 2008 Aug;37(4):597-601. https://www.ncbi.nlm.nih.gov/pubmed/19128600. Published 2008. Accessed September 20, 2017.
  16. National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Oral Cavity and Pharynx Cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program website. https://seer.cancer.gov/statfacts/html/oralcav.html . Updated April 5, 2018. Accessed May 7, 2018.
  17. Jou A, Hess J. Epidemiology and Molecular Biology of Head and Neck Cancer. Oncol Res Treat. 2017;40:328-332. https://doi.org/10.1159/000477127.
  18. Jain SK, Sikora AG, Baxi SS, Morris LG. Synchronous Cancers in Patients With Head and Neck Cancer Risks in the Era of Human Papillomavirus-Associated Oropharyngeal Cancer. Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988.
  19. National Institute for Communicable Diseases. South African National Cancer Registry. http://www.nicd.ac.za/centres/national-cancer-registry/. Updated 2019. Accessed October 09, 2017.
  20. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology 2017 3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
  21. National Comprehensive Cancer Network. Head and Neck Cancers: Very Advanced Head and Neck Cancers. National Comprehensive Cancer Network website. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck_blocks.pdf. Updated 2019. Accessed September 10, 2017.
  22. Western Cape Government. Tygerberg Hospital Overview. https://www.westerncape.gov.za/assets/departments/health/tygerberg_hospital_information_pamphlet_-_2016.pdf. Updated October 28, 2016. Accessed August 15, 2017.
  23. Kim S. Prognostic Factors in Patients with Head and Neck Cancer.Head and Neck cancer. A Multidisciplinary Approach . 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2009.p 87-104.
  24. Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayam, R. Epidemiology of cancer from the oral cavity and oropharynx.European Journal of Gastroenterology & Hepatology. 2011;23(8): 633-641. doi: 10.1097/MEG.0b013e3283484795.
  25. Larizadeh M, Damghani M, Shabani M. Epidemiological Characteristics of Head and Neck Cancers in Southeast of Iran. Iranian Journal of Cancer Prevention. 2014;7(2): 80-86. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142945/#idm140310782150208title. Accessed September 19, 2017.
  26. Marur S, Forastiere A. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clinic Proceedings . 2016;91(3): 386-396. doi: 10.1016/j.mayocp.2015.12.017.
  27. Pai S, Westra WH. Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment. Annual Review of Pathology . 2009;4: 49-10. https://doi.org/10.1146/annurev.pathol.4.110807.092158.
  28. Purgina B, Pantanowitz L, Seethala RR. A Review of Carcinomas Arising in the Head and Neck Region in HIV-Positive Patients. Pathology Research International. 2011, Article ID 469150, 12 pages. http://dx.doi.org/10.4061/2011/469150.
  29. Rajapakshe RMAR, Pallegama RW, Jayasooriya, PR, Siriwardena BS, Attygalla AM, Hewapathirana S, et al. A retrospective analysis to determine factors contributing to the survival of patients with oral squamous cell carcinoma. Cancer Epidemiology. 2015;39(3): 360-366. https://doi.org/10.1016/j.canep.2015.02.011.
  30. O’ Sullivan B, Hunag SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. The Lancet Oncology . 2016; 17(4): 440-51. doi: 10.1016/S1470-2045(15)00560-4.
  31. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol. 2015 Oct 10; 33(29): 3235–3242. doi: 10.1200/JCO.2015.61.6995.